<DOC>
	<DOCNO>NCT00920413</DOCNO>
	<brief_summary>People kidney failure risk development anemia . Anemia decrease production hemoglobin , substance carry oxygen blood . The majority patient require erythropoietin iron supplementation correct anemia . In patient , hemoglobin fails rise desire level despite treatment erythropoietin iron . There several study hemodialysis patient show vitamin C give intravenously help correct anemia patient already erythropoietin iron . The purpose study determine whether oral vitamin C improve parameter anemia patient receive peritoneal dialysis . Description research This randomize , double blind , placebo control study . Participants randomize 1:1 ratio oral vitamin C 500mg day placebo 3 month . All participant receive oral iron supplementation , subcutaneous erythropoietin B C complex vitamin contain 100mg vitamin C. Lab parameter ( hemoglobin , TSAT , ferritin ) do baseline monthly . The primary outcome percent change baseline transferrin saturation . Secondary objective percent change ferritin , hemoglobin erythropoietin dose baseline .</brief_summary>
	<brief_title>Oral Vitamin C Correction Anemia Patients Receiving Peritoneal Dialysis</brief_title>
	<detailed_description>Patients randomize 1:1 ratio Vitamin C 500mg orally daily match placebo 3 month . Randomization cod keep Research Pharmacy investigator patient blind treatment . Patients currently take vitamin C supplement ( exclude 100mg vitamin C contain B C complex vitamin , supplement use peritoneal dialysis patient ) , take vitamin C randomize one treatment arm 1 month washout period . At end 3 month , effect vitamin C change transferrin saturation baseline evaluate identify patient , , benefit treatment . Hemoglobin , serum iron , total iron binding capacity , ferritin , transferrin saturation erythropoietin dose also assess . The dose formulation recombinant erythropoietin oral iron adjust study period accord standard practice algorithms currently use clinic . The addition vitamin C pose risk patient dispense patient Research Pharmacy St. Michael 's Hospital free charge . Patient population Inclusion criterion Receiving peritoneal dialysis 2 month Exclusion criterion Red blood cell folate &lt; 3.9 nmol/L Serum B12 &lt; 110 pmol/L Bleeding , blood transfusion , acute liver disease previous 3 month Assessments Parathyroid hormone Baseline B12 Baseline Folate Baseline Hemoglobin Baseline monthly Hematocrit Baseline monthly Ferritin Baseline monthly Transferrin saturation Baseline monthly Serum iron Baseline monthly</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>Receiving peritoneal dialysis 2 month Red blood cell folate &lt; 3.9 nmol/L Serum B12 &lt; 110 pmol/L Bleeding , blood transfusion , acute liver disease previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>